![Donald Keyser](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Donald Keyser
Presidente presso LANTERN PHARMA INC.
Patrimonio netto: 195 799 $ in data 30/06/2024
Posizioni attive di Donald Keyser
Società | Posizione | Inizio | Fine |
---|---|---|---|
LANTERN PHARMA INC. | Independent Dir/Board Member | 01/01/2018 | - |
Presidente | 01/11/2019 | - | |
Direttore/Membro del Consiglio | 01/01/2018 | 01/11/2019 | |
Renibus Therapeutics, Inc.
![]() Renibus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Renibus Therapeutics, Inc. engages in manufacture of pharmaceutical products. The company was founded by Donald Jeffrey Keyser and Alvaro F. Guillem in 2015 and is headquartered in Southlake, TX. | Direttore/Membro del Consiglio | 01/01/2015 | - |
Amministratore Delegato | 21/03/2024 | - | |
Direttore operativo | 01/01/2015 | - | |
Fondatore | 01/01/2015 | - | |
Presidente | 01/01/2015 | - | |
Segretario Aziendale | 01/01/2015 | - |
Storia della carriera di Donald Keyser
Precedenti posizioni note di Donald Keyser
Società | Posizione | Inizio | Fine |
---|---|---|---|
ZS PHARMA INC | Direttore/Membro del Consiglio | 05/02/2008 | 01/05/2015 |
Direttore operativo | 05/02/2008 | 01/12/2015 | |
Fondatore | 09/06/2010 | 01/12/2015 | |
Segretario Aziendale | 05/02/2008 | 01/05/2015 | |
Encysive Pharmaceuticals, Inc.
![]() Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Responsabile della Conformità | 01/01/2004 | - |
Consigliere Generale | 01/01/2004 | - | |
Adams Respiratory Therapeutics, Inc.
![]() Adams Respiratory Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adams Respiratory Therapeutics, Inc. manufactures over-the-counter remedies for respiratory ailments. The company's products include Mucinex, Mucinex DM, Maximum Strength Mucinex, Mucinex DM, Mucinex D, and the Delsym. It is a subsidiary of Reckitt Benckiser Corp. Adams Respiratory Therapeutics is headquartered in Chester, NJ | Consigliere Generale | 01/01/1998 | 01/01/2004 |
Marion Laboratories | Corporate Officer/Principal | 01/01/1985 | 01/01/1991 |
Marion Merrell Dow, Inc. | Consigliere Generale | - | - |
ABBOTT LABORATORIES | Corporate Officer/Principal | - | - |
Medeva Americas, Inc. | Consigliere Generale | - | - |
░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░░ | - | - |
Formazione di Donald Keyser
Creighton University | Graduate Degree |
University of Missouri-Kansas City | Graduate Degree |
The University of Texas at Dallas | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 14 |
Posizioni
General Counsel | 5 |
Director/Board Member | 3 |
Graduate Degree | 2 |
Settori
Health Technology | 8 |
Consumer Services | 4 |
Distribution Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
ABBOTT LABORATORIES | Health Technology |
LANTERN PHARMA INC. | Health Technology |
Aziende private | 8 |
---|---|
Adams Laboratories, Inc. | |
Marion Laboratories | Distribution Services |
ZS Pharma, Inc.
![]() ZS Pharma, Inc. Pharmaceuticals: MajorHealth Technology ZS Pharma, Inc. engages in the development of development and commercialization of non-absorbed drugs to treat renal, cardiovascular, liver and metabolic diseases. It develops treatment of hyperkalemia. It also focuses on clinical development, novel technology, and clinical trials. The company was founded by Alvaro F. Guillem and Donald Jeffrey Keyser on February 5, 2008 and is headquartered in San Mateo, CA. | Health Technology |
Adams Respiratory Therapeutics, Inc.
![]() Adams Respiratory Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adams Respiratory Therapeutics, Inc. manufactures over-the-counter remedies for respiratory ailments. The company's products include Mucinex, Mucinex DM, Maximum Strength Mucinex, Mucinex DM, Mucinex D, and the Delsym. It is a subsidiary of Reckitt Benckiser Corp. Adams Respiratory Therapeutics is headquartered in Chester, NJ | Health Technology |
Encysive Pharmaceuticals, Inc.
![]() Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Health Technology |
Medeva Americas, Inc. | |
Renibus Therapeutics, Inc.
![]() Renibus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Renibus Therapeutics, Inc. engages in manufacture of pharmaceutical products. The company was founded by Donald Jeffrey Keyser and Alvaro F. Guillem in 2015 and is headquartered in Southlake, TX. | Health Technology |
Marion Merrell Dow, Inc. | Health Technology |
- Borsa valori
- Insiders
- Donald Keyser
- Esperienza